Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 42:1967-1974, doi:10.1016/j.jacc.2003.07.024
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ng, M. K. C.
Right arrow Articles by Celermajer, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ng, M. K. C.
Right arrow Articles by Celermajer, D. S.

Dehydroepiandrosterone, an adrenalandrogen, increases human foam cell formation

a potentially pro-atherogenic effect

Martin K. C. Ng, MBBS, FRACP*{dagger}, Shirley Nakhla, BSc{dagger}, Anna Baoutina, PhD{ddagger}, Wendy Jessup, PhD{ddagger}, David J. Handelsman, MBBS, PhD, FRACP§|| and David S. Celermajer, MBBS, PhD, FRACP*{dagger},*

* Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia
{dagger} Heart Research Institute, Sydney, Australia
{ddagger} Centre for Vascular Research, University of New South Wales, Sydney, Australia
§ Department of Andrology, Concord Hospital, Sydney, Australia
|| ANZAC Research Institute, Sydney, Australia



View larger version (53K):

[in a new window]
 
Figure 1 Monocyte adhesion to endothelium (in the basal or interleukin-1-beta [IL-1-beta]–stimulated state) for each treatment condition, expressed as a percentage of control values. Dehydroepiandrosterone (DHEA) (in young adults and at supraphysiologic concentrations) had no significant effect on monocyte adhesion to endothelium (p = 0.56 by analysis of variance [ANOVA] for adhesion in either the basal or IL-1-beta–stimulated state).

 


View larger version (106K):

[in a new window]
 
Figure 2 Endothelial cell-surface expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and E-selectin for each treatment group in the basal (A) and IL-1-beta–stimulated (B) states. Results are expressed as a percentage of control values. DHEA had no significant effect on endothelial cell-surface expression of VCAM-1, ICAM-1, or E-selectin (p > 0.1 by ANOVA for each cell adhesion molecule [CAM] in each treatment group). Abbreviations as in Figure 1.

 


View larger version (45K):

[in a new window]
 
Figure 3 Exposure to DHEA was associated with a dose-dependent increase in cholesteryl ester (CE) accumulation in human macrophages from male donors, over the physiologic range (4.2 to 42 nmol/l). This effect is abrogated by co-incubation with the androgen receptor antagonist HF. *p = 0.015 by ANOVA. There was a polynomial relationship between the DHEA concentration and macrophage CE content (r = 0.997). Abbreviations as in Figure 1.

 


View larger version (24K):

[in a new window]
 
Figure 4 Effects of dehydroepiandrosterone (DHEA) exposure on macrophage gene expression. (A) Gene expression examined by reverse-transcription polymerase chain reaction shows that DHEA at physiologic concentrations upregulates the lipoprotein-processing genes acyl coenzyme A:cholesterol acyltransferase I (ACAT) and lysosomal acid lipase (LAL). (B) In contrast, DHEA exposure had no significant effect on expression of the scavenger receptors A1 and A2. *p < 0.05 versus control values for ACAT and LAL (vs. p > 0.2 for scavenger receptors A1 and 2). Open columns = control; shaded columns = DHEA at 42 nmol/l.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement